Hope For Huntington's Disease
A study published in EMBO Molecular Medicine shows that an experimental drug, anle138b, reduces toxic protein clumps and extends the lifespan of mice with Huntington's disease. Researchers are now looking to determine if these findings can be translated into human treatments.
Why it matters
Offers potential hope for treating Huntington's disease, a currently incurable hereditary disorder, by targeting its underlying biological cause.
An experimental drug has been shown to alleviate symptoms of Huntington's disease and extend lifespan in mouse models. Further studies are required to determine whether these results may also apply to humans.
The article summarizes medical research findings objectively.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in